MedTrace Logo

Ovarian Response Prediction in In Vitro Fertilization (IVF) Patients

NCT01206803 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 294

Last updated 2016-01-05

No results posted yet for this study

Summary

The aim of the study is to explore ovarian response in terms of oocyte numbers after ovarian stimulation in a fixed gonadotropin dose GnRH-antagonist protocol by endocrine (AMH, FSH), demographic (age), sonographic (antral follicle count) and genetic factors (polymorphisms of gonadotropin receptors and secreted gonadotropins).

Conditions

  • Infertility, Subfertility

Interventions

DRUG

Ovarian stimulation in a GnRH-antagonist protocol

Long-acting FSH 150µg \& daily recombinant FSH 200 IU, GnRH-antagonist 0.25mg, 5,000-10,000 IU urinary hCG, triptorelin 0.2mg, vaginal progesterone

Sponsors & Collaborators

  • University Hospital Schleswig-Holstein

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2013-12-31
Completion
2014-01-31

Countries

  • Germany
  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01206803 on ClinicalTrials.gov